Lamivudine is a nucleoside reverse transcriptase inhibitor, which can treat hepatitis B by preventing the virus from replicating in the body. It combines with viral DNA to prevent virus replication, thus alleviating the symptoms of patients. Lamivudine is taken orally, and the routine dose is once a day, which is used for the treatment of adults and children.
Afuddin is a nucleic acid polymerase inhibitor and a selective virus inhibitor, similar to lamivudine. Afuddin inhibits the synthesis of viral DNA and prevents it from further replication. Unlike lamivudine, afudine needs interferon treatment. Afuddin can be taken orally or injected. The routine dose varies according to the patient's condition, usually once a day.
Generally speaking, although the mechanism of action of lamivudine and afudine is similar, the use method and dosage are different. Patients should choose appropriate drugs and doses for treatment according to the doctor's advice.